FCMI
Foresite Capital Management IV Portfolio holdings
AUM
$124M
1-Year Return
24.36%
This Quarter Return
-12%
1 Year Return
-24.36%
3 Year Return
+1.86%
5 Year Return
+16.17%
10 Year Return
–
AUM
$306M
AUM Growth
-$42.3M
(-12%)
Cap. Flow
+$421K
Cap. Flow
% of AUM
0.14%
Top 10 Holdings %
Top 10 Hldgs %
82.21%
Holding
22
New
2
Increased
3
Reduced
9
Closed
5
Top Buys
| 1 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
+$15.4M |
| 2 |
MDCO
Medicines Co
MDCO
|
+$11.4M |
| 3 |
Fulcrum Therapeutics
FULC
|
+$11.2M |
| 4 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
+$6.63M |
| 5 |
Voyager Therapeutics
VYGR
|
+$5.06M |
Top Sells
| 1 |
Replimune Group
REPL
|
+$18M |
| 2 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
+$6.9M |
| 3 |
Veracyte
VCYT
|
+$5.7M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
+$5.07M |
| 5 |
Alector
ALEC
|
+$2.99M |
Sector Composition
| 1 | Healthcare | 81.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TPTX
1
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $68.7M | 22.19% |
1,826,374
-3,891
| -0.2% | -$146K |
|
|
AERI
2
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $26.9M | 8.7% |
1,400,900
+800,900
| +133% | +$15.4M |
|
3
Insmed
INSM
$30.8B
| $25.2M | 8.15% |
1,429,518
-131,667
| -8% | -$2.32M |
|
|
MDCO
4
DELISTED
Medicines Co
MDCO
| $23.9M | 7.73% |
478,217
+228,545
| +92% | +$11.4M |
|
5
Ascendis Pharma
ASND
$12B
| $23.6M | 7.64% |
245,424
| – | – |
|
6
Cytokinetics
CYTK
$6.38B
| $21.6M | 6.98% |
1,898,970
| – | – |
|
|
BHVN
7
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $17.8M | 5.74% |
425,794
-3,896
| -0.9% | -$163K |
|
|
OPTN
8
DELISTED
OptiNose
OPTN
| $15.7M | 5.06% |
149,200
-18,946
| -11% | -$1.99M |
|
|
9
Voyager Therapeutics
VYGR
$243M
| $14.3M | 4.62% |
830,565
+293,794
| +55% | +$5.06M |
|
|
10
Alector
ALEC
$290M
| $13.5M | 4.36% |
936,371
-207,091
| -18% | -$2.99M |
|
|
MYOK
11
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $12.4M | 4.01% |
238,186
-19,266
| -7% | -$1M |
|
|
12
Fulcrum Therapeutics
FULC
$378M
| $11.2M | 3.62% |
+1,687,500
| New | +$11.2M |
|
|
CBAY
13
DELISTED
Cymabay Therapeutics
CBAY
| $10.5M | 3.41% |
2,060,268
-510,990
| -20% | -$2.62M |
|
|
ORTX
14
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $6.63M | 2.14% |
+55,770
| New | +$6.63M |
|
|
15
Rhythm Pharmaceuticals
RYTM
$6.5B
| $5.06M | 1.64% |
234,482
-235,000
| -50% | -$5.07M |
|
|
IMMU
16
DELISTED
Immunomedics Inc
IMMU
| $4.88M | 1.58% |
367,636
-18,115
| -5% | -$240K |
|
17
SI-BONE Inc
SIBN
$704M
| $3.63M | 1.17% |
205,621
| – | – |
|
18
Kiniksa Pharmaceuticals
KNSA
$2.74B
| – | – |
-63,922
| Closed | -$866K |
|
|
19
Replimune Group
REPL
$469M
| – | – |
-1,228,656
| Closed | -$18M |
|
|
20
Veracyte
VCYT
$2.51B
| – | – |
-200,000
| Closed | -$5.7M |
|
|
NGM
21
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| – | – |
-471,269
| Closed | -$6.9M |
|
22
Arbutus Biopharma
ABUS
$939M
| – | – |
-608,151
| Closed | -$1.27M |
|